China's booming biotech, from a brain implant to drug discovery

In March, China became the first country to approve an invasive brain-computer interface beyond clinical trials. The implant, called NEO, is now available to some patients with limb paralysis due to a spinal cord injury. Ira talks with Wired staff writer Emily Mullin about the significance of this milestone.

Plus, brain implants aren’t the only development: China’s entire biotech industry (sciencefriday.com/segments/china-biotech-indus…?) has skyrocketed in recent years. A decade ago, about 8% of new drug molecules were discovered in China. Now it's over 40%. And more clinical trials are now being conducted there than in the U.S. or Europe. Ira talks with health policy researcher So-Yeon Kang, who’s been following the Chinese pharma industry’s meteoric rise.

Guests:

Emily Mullin is a staff writer at Wired.

Dr. So-Yeon Kang is an Assistant Professor of Health Management and Policy at Georgetown University.

Other episodes you may enjoy:

• Advances In Brain-Computer Interfaces For People With Paralysis (sciencefriday.com/segments/brain-computer-inte…?)

• How China Is Driving Down Electricity Costs With Renewables (sciencefriday.com/segments/china-solar-wind-re…?)

Transcripts for each episode are available within 1-3 days at sciencefriday.com/segments/china-biotech-indus…

Subscribe to this podcast. (pod.link/73329284) Follow our show on Instagram (instagram.com/scifri), TikTok (tiktok.com/@scifri), Facebook (facebook.com/scifri), and Bluesky (bsky.app/profile/scifri.bsky.social) @scifri and sign up for our newsletters (sciencefriday.com/newsletters/?utm_source=wnyc…). Got a science question that’s keeping you up at night? Call us: 877-472-4374

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.